A detailed history of Monetary Management Group Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Monetary Management Group Inc holds 16,130 shares of LLY stock, worth $13 Million. This represents 3.69% of its overall portfolio holdings.

Number of Shares
16,130
Previous 16,305 1.07%
Holding current value
$13 Million
Previous $14.8 Million 3.2%
% of portfolio
3.69%
Previous 3.92%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $135,124 - $168,003
-175 Reduced 1.07%
16,130 $14.3 Million
Q2 2024

Jul 16, 2024

SELL
$724.87 - $909.04 $340,688 - $427,248
-470 Reduced 2.8%
16,305 $14.8 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $171,738 - $229,761
-290 Reduced 1.7%
16,775 $13.1 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $97,160 - $114,539
-185 Reduced 1.07%
17,065 $9.95 Million
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $43,470 - $59,929
-100 Reduced 0.58%
17,250 $9.27 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $410,365 - $548,706
-1,170 Reduced 6.32%
17,350 $8.14 Million
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $18,637 - $21,889
-60 Reduced 0.32%
18,520 $6.36 Million
Q4 2022

Feb 13, 2023

SELL
$321.55 - $374.67 $274,925 - $320,342
-855 Reduced 4.4%
18,580 $6.8 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $523,287 - $596,340
-1,765 Reduced 8.33%
19,435 $6.28 Million
Q2 2022

Aug 11, 2022

SELL
$278.73 - $327.27 $62,714 - $73,635
-225 Reduced 1.05%
21,200 $6.87 Million
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $28,162 - $34,999
-120 Reduced 0.56%
21,425 $6.14 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $412,599 - $512,038
1,835 Added 9.31%
21,545 $5.95 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $99,720 - $122,719
450 Added 2.34%
19,710 $4.55 Million
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $76,733 - $99,254
-425 Reduced 2.16%
19,260 $4.42 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $82,160 - $106,360
500 Added 2.61%
19,685 $3.68 Million
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $666,763 - $771,232
4,560 Added 31.18%
19,185 $2.84 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $88,672 - $106,717
-650 Reduced 4.26%
14,625 $2.4 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $44,643 - $55,256
-375 Reduced 2.4%
15,275 $2.12 Million
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $10,692 - $13,243
-100 Reduced 0.63%
15,650 $2.06 Million
Q3 2019

Nov 12, 2019

SELL
$106.79 - $116.16 $10,679 - $11,616
-100 Reduced 0.63%
15,750 $1.76 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $50,089 - $58,959
-450 Reduced 2.76%
15,850 $2.06 Million
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $58,245 - $65,252
-550 Reduced 3.26%
16,300 $1.89 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $8,586 - $10,731
-100 Reduced 0.59%
16,850 $1.81 Million
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $33,394 - $39,420
-450 Reduced 2.59%
16,950 $1.31 Million
Q4 2017

Feb 14, 2018

SELL
$81.94 - $87.89 $8,194 - $8,789
-100 Reduced 0.57%
17,400 $1.47 Million
Q3 2017

Nov 13, 2017

SELL
$77.07 - $85.54 $2,697 - $2,993
-35 Reduced 0.2%
17,500 $1.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
17,535
17,535 $1.44 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $764B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Monetary Management Group Inc Portfolio

Follow Monetary Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monetary Management Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monetary Management Group Inc with notifications on news.